User profiles for A Jahun
 | Aminu S. JahunDepartment of Pathology, University of Cambridge Verified email at cam.ac.uk Cited by 5220 |
[HTML][HTML] SARS-CoV-2 evolution during treatment of chronic infection
, … logistics and sequencing & analysis Jahun Aminu S. 85 … - Nature, 2021 - nature.com
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …
[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
…, WL Hamilton, IG Goodfellow, G Hall, AS Jahun… - Cell, 2021 - cell.com
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …
are suggestive of a selective advantage but may also be due to a random founder effect. We …
[HTML][HTML] Evolution of enhanced innate immune evasion by SARS-CoV-2
The emergence of SARS-CoV-2 variants of concern suggests viral adaptation to enhance
human-to-human transmission 1 , 2 . Although much effort has focused on the characterization …
human-to-human transmission 1 , 2 . Although much effort has focused on the characterization …
[PDF][PDF] Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
…, IG Goodfellow, G Hall, AS Jahun… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …
England. We aimed to investigate whether increases in the proportion of infections with this …
[HTML][HTML] Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study
…, CJ Houldcroft, M Hosmillo, AS Jahun… - The Lancet infectious …, 2020 - thelancet.com
Background The burden and influence of health-care associated severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections is unknown. We aimed to examine the use …
syndrome coronavirus 2 (SARS-CoV-2) infections is unknown. We aimed to examine the use …
[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …
…, W Hamilton, I Goodfellow, G Hall, A Jahun… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
[HTML][HTML] Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
Patterns of within-host genetic diversity in SARS-CoV-2
Monitoring the spread of SARS-CoV-2 and reconstructing transmission chains has become
a major public health focus for many governments around the world. The modest mutation …
a major public health focus for many governments around the world. The modest mutation …
[HTML][HTML] Evolution of enhanced innate immune evasion by the SARS-CoV-2 B. 1.1. 7 UK variant
Emergence of SARS-CoV-2 variants, including the globally successful B. 1.1. 7 lineage,
suggests viral adaptations to host selective pressures resulting in more efficient transmission. …
suggests viral adaptations to host selective pressures resulting in more efficient transmission. …